However, in a previous study, it has been reported that EPO decreases blood glucose levels in obese mice that are susceptible to diabetes and obesity through decreasing body weight and lowering hemoglobin A1c [27]. This evidence concerns the gene EPO and obesity due to melanocortin 4 receptor deficiency.